Hochschule
THE INFECTIOUS DISEASES INSTITUTE LIMITED
THE INFECTIOUS DISEASES INSTITUTE LIMITED – Hochschule bzw. Forschungseinrichtung mit Aktivitäten in Forschung und Innovation.
Weiter entdecken
Ähnliche Beiträge
Projekt
→
Kits for advanced polymer-lipid nanocarriers for targeted delivery of RNAs to cardiac and skeletal muscle cells
Currently, RNA therapies are available on the clinics to treat liver diseases and as COVID-19 vaccines. Hence, their therapeutic… Beitrag ansehen →
Projekt
→
Beyond COVID
Beyond-COVID (BY-COVID) aims to provide comprehensive open data on SARS-CoV-2, and other infectious diseases across scientific, m… Beitrag ansehen →
Projekt
→
SUStainable Antimicrobial and Antiviral Nanocoating
Infectious diseases pose a significant threat to both human health and the global economy, they account for more than 20% of glob… Beitrag ansehen →
Projekt
→
Sustainable Development of a Safe and Biobased Antimicrobial, Antifungal and Antiviral Nanocoating Platform
Human pathogens can persist on textiles and high-traffic surfaces for hours, days or even longer when protected in biofilms, incr… Beitrag ansehen →
Projekt
→
Integrated Services for Infectious Disease Outbreak Research
The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, proposes to assemble t… Beitrag ansehen →
Projekt
→
Deconstructing and Rewiring RNA-RBP regulatory networks
RNA-binding proteins (RBPs) are critical regulators of gene expression programs. They regulate all aspects of RNA life, including… Beitrag ansehen →
Passend zu diesem Beitrag
Forschungsprojekte
- Implementation of an upgraded strategy to reach zero HIV transmission by breastfeeding in rural and urban settings in Zambia – the PROMISE-ZERO study Most cases of paediatric HIV now occur during the breastfeeding period. Through an EDCTP-2 funded randomized… →
- SCALING UP CAPACITY TO SUPPORT CONDUCT OF CLINICAL TRIALS IN THE EAST AFRICAN COMMUNITY The East African Community (EAC) has experienced significant increase in volume and complexity of clinical re… →
- Drug Optimisation in LMICs of Pregnant HIV women and their Infants: temporary switch to CAB/RPV long acting injections Sustained ART use is essential for achieving SDG3 by reducing HIV burden and promoting maternal and infant he… →